Delays continue of EU EDC Strategy
Continuous setbacks of the EU EDC revised strategy mean lost opportunities for prevention of chronic disease and healthcare savings. At the beginning of 2014, the strategy is still not out.
Consultations within the Commission are apparently still ongoing.
HEAL and other NGOs believe the new Strategy must do the following:
1. Set the framework for reducing the exposures of the public and the environment to existing EDCs as a matter of urgency.
2. Lay out a timetable for a systematic overhaul of all relevant existing legislation and propose new legislation where needed to address the EDC exposures across all sectors.
3. Coordinate and help fund European-wide human biomonitoring, so that people’s exposures are better known.
4. Set out an ambitious research and development strategy.
5. Facilitate and accelerate substitution to safer alternatives for known and suspected EDCs.
6. Swiftly improve the screening and testing system for chemicals with ED properties and install adequate testing requirements in all relevant legislation, as well as ensure non-discriminatory use of different types of studies and tests in the assessment of chemicals.
Meanwhile, the Progressive Alliance of Socialists & Democrats in the European Parliament (S&D) strongly criticised the EU Commission for delaying action on endocrine disruptors, noting that the delay in the publishing of the criteria (to identify and assess endocrine disruptors as per the pesticides and biocides laws) meant no EU legislation n a problem that clearly needs action to protect citizens’ health. More information in their press release here
In Spain and France the public health and medical community is also urging the EU Commission not to delay its revised strategy. 3,800 Spanish public health experts have called on Spain’s Minister of Health and the EU Commission to adopt a stricter regulation of EDCs.
Originally posted on 6 February 2014